BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6287725)

  • 1. [Circulating immunocomplexes in lung neoplasms].
    Pesek M; Sefrna F; Simecek C; Racek J
    Vnitr Lek; 1982 Jun; 28(6):571-6. PubMed ID: 6287725
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunocomplexes and primary lung cancer.
    Lenzini L; Rottoli L; Sestini P; Carriero G; Sani G; Gotti G
    Allergol Immunopathol (Madr); 1981; 9(2):119-22. PubMed ID: 6270995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Demonstration of antibodies against tumor-associated antigens in the serum patients with bronchogenic carcinoma using anticomplement immunofluorescence on xenotransplants of human tumors].
    Stiller-Winkler R; Stark M; Idel H
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Mar; 180(4):381-93. PubMed ID: 2988233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunological status in small cell and squamous cell lung cancer].
    Janicka G; Przylipiak M; Chyczewska E; Kowal E
    Pol Tyg Lek; 1983 Aug; 38(32):985-8. PubMed ID: 6320142
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-specific immunostimulation in bronchogenic cancer.
    Israel L
    Scand J Respir Dis Suppl; 1974; 89():95-105. PubMed ID: 4370224
    [No Abstract]   [Full Text] [Related]  

  • 6. Diminished lymphocyte responses to phytohemagglutinin in lung cancer.
    Hadjipetrou-Kourounakis L; Tsougranis A
    Biochem Exp Biol; 1980; 16(4):357-64. PubMed ID: 6285942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Circulating immune complexes and bronchopulmonary cancers].
    Pourrat JP; Leophonte P; Pourrat E; Mouysset B; Conte JJ; Delaude A
    Rev Mal Respir; 1984; 1(1):31-6. PubMed ID: 6611568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunocytology of cancer.
    Davidsohn I; Ni LY
    Acta Cytol; 1970 May; 14(5):276-82. PubMed ID: 4935158
    [No Abstract]   [Full Text] [Related]  

  • 9. Skin test in bronchogenic carcinoma. I. Correlation of the immunological status and the extent of the disease.
    Takita H; Brugarolas A
    J Surg Oncol; 1973; 5(4):315-8. PubMed ID: 4355620
    [No Abstract]   [Full Text] [Related]  

  • 10. [Activated cells in the peripheral blood in lung cancer].
    Qian L
    Zhonghua Jie He He Hu Xi Za Zhi; 1988 Feb; 11(1):18-21, 62. PubMed ID: 2848634
    [No Abstract]   [Full Text] [Related]  

  • 11. [Phagocytic activity in various lung tumors].
    Mikhova Ts; Uzunov P; Vlasov V; Vodenicharova S
    Eksp Med Morfol; 1988; 27(3):39-43. PubMed ID: 2851435
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumor associated antigen with pulmonary neoplasms.
    Lo Gerfo P; Herter FP; Braun J; Hansen HJ
    Ann Surg; 1972 Apr; 175(4):495-500. PubMed ID: 4336486
    [No Abstract]   [Full Text] [Related]  

  • 13. Response of the secretory immune system to bronchogenic carcinoma of the lung.
    Iglehart JD; Montelaro RC; Bolognesi DP; Sabiston DC; Wolfe WG
    Surg Forum; 1979; 30():118-9. PubMed ID: 231845
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serum concentration of C3 in primary lung cancer patients].
    Bariffi F; Marsico SA; Vigorito C; Alfani G; Donato Di Paola RM
    Arch Monaldi; 1980; 35(4):169-74. PubMed ID: 6282231
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunologic impairment in bronchogenic carcinoma: a study of lymphocyte response to phytohemagglutinin.
    Han T; Takita H
    Cancer; 1972 Sep; 30(3):616-20. PubMed ID: 4342406
    [No Abstract]   [Full Text] [Related]  

  • 16. [Delayed immunity in bronchial cancer: lymphocyte activation in culture with phytohemagglutinins and tuberculin PPD compared with the skin response to tubercular antigens].
    Piacentini G; Ferrari S; Megale C; Ippoliti F
    Boll Ist Sieroter Milan; 1973; 52(3):230-6. PubMed ID: 4762779
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunologic status in lung cancer.
    Brugarolas A; Takita H
    Chest; 1973 Oct; 64(4):427-30. PubMed ID: 4355273
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunological monitoring of patients operated on for epidermoid bronchogenic carcinoma].
    Dominioni L; Dionigi R; Cremaschi P; Nascimbene C; Cividini F; Mori A; Pecis C; Asti S; Moncalvo F; Campani M
    Chir Ital; 1981 Feb; 33(1):47-59. PubMed ID: 7261218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunomorphology of lymph nodes and prognosis in lung cancer].
    Di Giorgio A; Sammartino P; Canavese A; Arnone P; Sibio S; Accarpio F; Al Mansour M
    Minerva Chir; 2001 Apr; 56(2):153-9. PubMed ID: 11353348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour-associated antigens in lung cancer: the possibility for a serologic assay.
    Kelly BS; Levy JG
    Can Med Assoc J; 1980 May; 122(9):1020-3. PubMed ID: 7370881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.